SCOPUS 정보 검색 플랫폼

Volumn 72, Issue 3-4, 2010, Pages 255-264

LC-MS-MS separation and simultaneous determination of tolterodine and its active metabolite, 5-hydroxymethyl tolterodine in human plasma

(8) Yadav, Manish a,c Upadhyay, Vivek a Chauhan, Vipul a Solanki, Gajendra a Jani, Alpa a Baxi, Girin A c Singhal, Puran a Shrivastav, Pranav S b

a Veeda Clinical Research India (India)

b GUJARAT UNIVERSITY (India)

c KSKV Kachchh University (India)

Author keywords

5 hydroxymethyl tolterodine; Column liquid chromatography tandem mass spectrometry; Tolterodine

Indexed keywords

5 HYDROXYMETHYL TOLTERODINE; ACETONITRILE; AMMONIUM FORMATE; DRUG METABOLITE; TOLTERODINE; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; DRUG BLOOD LEVEL; DRUG DETERMINATION; HUMAN; HUMAN EXPERIMENT; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84755161322 PISSN: 00095893 EISSN: 16121112 Source Type: Journal
DOI: 10.1365/s10337-010-1667-x Document Type: Article

Times cited : (9)

References (21)

1
- 0030997354
- doi:10.1016/S0014-2999 97 89661-6
- Nilvebrant L, Andersson K-E, Gillberg P-G, Stahl MMS, Sparf B (1997) Eur J Pharmacol 327:195-207. doi:10.1016/S0014-2999 (97) 89661-6
- (1997) Eur. J. Pharmacol. , vol.327 , pp. 195-207
- Nilvebrant, L.¹ Andersson, K.-E.² Gillberg, P.-G.³ Stahl, M.M.S.⁴ Sparf, B.⁵

2
- 43049159476
- Tolterodine for the treatment of overactive bladder
- DOI 10.1517/14656566.9.7.1249
- Salvatore S, Serati M, Bolis P (2008) Expert Opin Pharmacother 9:1249-1255. doi:10.1517/14656566.9.7.1249 (Pubitemid 351727807)
- (2008) Expert Opinion on Pharmacotherapy , vol.9 , Issue.7 , pp. 1249-1255
- Salvatore, S.¹ Serati, M.² Bolis, P.³

3
- 0031309603
- doi:10.1016/S0090-4295 97 00595-5
- Andersson K-E (1997) Urology 50:74-84. doi:10.1016/S0090-4295 (97) 00595-5
- (1997) Urology , vol.50 , pp. 74-84
- Andersson, K.-E.¹

4
- 0031804227
- doi:35400007564348. 0080
- Hills CJ, Winter SA, Balfour JA (1998) Drugs 55:813-822. doi:35400007564348. 0080
- (1998) Drugs , vol.55 , pp. 813-822
- Hills, C.J.¹ Winter, S.A.² Balfour, J.A.³

5
- 0035126767
- doi:10.1016/S0090-4295 00 01113-4
- Kerrebroeck PV, Kreder K, Jonas U, Zinner N, Wein A (2001) Urology 57:414-421. doi:10.1016/S0090-4295 (00) 01113-4
- (2001) Urology , vol.57 , pp. 414-421
- Kerrebroeck, P.V.¹ Kreder, K.² Jonas, U.³ Zinner, N.⁴ Wein, A.⁵

6
- 0033981114
- Nilvebrant L (2000) Rev Contemp Pharmacother 11:13-27
- (2000) Rev. Contemp Pharmacother. , vol.11 , pp. 13-27
- Nilvebrant, L.¹

7
- 0029620283
- Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivity
- DOI 10.1002/nau.1930140606
- Stahl MMS, Eckstrom B, Sparf B, Mattiasson A, Andersson K-E (1995) Neurourol Urodyn 14:647-655. doi:10.1002/nau.1930140606 (Pubitemid 26025479)
- (1995) Neurourology and Urodynamics , vol.14 , Issue.6 , pp. 647-655
- Stahl, M.M.S.¹ Ekstrom, B.² Sparf, B.³ Mattiasson, A.⁴ Andersson, K.-E.⁵

8
- 0031918465
- doi:0090-9556/98/2604-0289-293
- Postlind H, Danielson A, Lindgren A, Andersson SH (1998) Drug Metab Dispos 26:289-293. doi:0090-9556/98/2604-0289-293
- (1998) Drug Metab. Dispos , vol.26 , pp. 289-293
- Postlind, H.¹ Danielson, A.² Lindgren, A.³ Andersson, S.H.⁴

9
- 0031836669
- doi:10.1016/S0009-9236 98 90104-7
- Brynne N, Dalen P, Alvan G, Bertilsson L, Gabrielsson J (1998) Clin Pharmacol Ther 63:529-539. doi:10.1016/S0009-9236 (98) 90104-7
- (1998) Clin. Pharmacol. Ther. , vol.63 , pp. 529-539
- Brynne, N.¹ Dalen, P.² Alvan, G.³ Bertilsson, L.⁴ Gabrielsson, J.⁵

10
- 33748979164
- doi:10.1016/j.ucl.2006. 06.004
- Kanofsky JA, Nitti VW (2006) Urol Clin N Am 33:447-453. doi:10.1016/j.ucl.2006. 06.004
- (2006) Urol. Clin. N. Am. , vol.33 , pp. 447-453
- Kanofsky, J.A.¹ Nitti, V.W.²

11
- 24044453421
- doi:10.1016/j. jchromb.2005.07.010
- Zhang B, Zhang Z, Tian Y, Xu F (2005) J Chromatogr B 824:92-98. doi:10.1016/j. jchromb.2005.07.010
- (2005) J. Chromatogr. B. , vol.824 , pp. 92-98
- Zhang, B.¹ Zhang, Z.² Tian, Y.³ Xu, F.⁴

12
- 4344615477
- A validated chiral HPLC method for the enantiomeric separation of tolterodine tartarate
- DOI 10.1016/j.jpba.2004.03.026, PII S0731708504001876
- Kumar YR, Ramulu G, Vevakanand VV, Vaidyanathan G, Srinivas K, Kumar MK, Mukkanti K, Reddy MS, Venkatraman S, Suryanarayana MV (2004) J Pharm Biomed Anal 35:1279-1285. doi:10.1016/j.jpba.2004.03.026 (Pubitemid 39140293)
- (2004) Journal of Pharmaceutical and Biomedical Analysis , vol.35 , Issue.5 , pp. 1279-1285
- Kumar, Y.R.¹ Ramulu, G.² Vevakanand, V.V.³ Vaidyanathan, G.⁴ Srinivas, K.⁵ Kumar, M.K.⁶ Mukkanti, K.⁷ Reddy, M.S.⁸ Venkatraman, S.⁹ Suryanarayana, M.V.¹⁰

13
- 51749095280
- doi:10.1365/s10337-008-0735-y
- Madhavi A, Reddy GS, Suryanarayana MV, Naidu A (2008) Chromatographia 68:399-407. doi:10.1365/s10337-008-0735-y
- (2008) Chromatographia , vol.68 , pp. 399-407
- Madhavi, A.¹ Reddy, G.S.² Suryanarayana, M.V.³ Naidu, A.⁴

14
- 0031239383
- doi:10.1016/S0731-7085 97 00023-X
- Palmer L, Andersson L, Andersson T, Stenberg U (1997) J Pharm Biomed Anal 16:155-165. doi:10.1016/S0731-7085 (97) 00023-X
- (1997) J. Pharm. Biomed. Anal. , vol.16 , pp. 155-165
- Palmer, L.¹ Andersson, L.² Andersson, T.³ Stenberg, U.⁴

15
- 0032545338
- doi: 10.1016/S0021-9673 98 00788-2
- Swart R, Koivisto P, Markides KE (1998) J Chromatogr A 828:209-218. doi: 10.1016/S0021-9673 (98) 00788-2
- (1998) J. Chromatogr. A , vol.828 , pp. 209-218
- Swart, R.¹ Koivisto, P.² Markides, K.E.³

16
- 0032755446
- doi: 10.1016/S0378-4347 99 00462-4
- Swart R, Koivisto P, Markides KE (1999) J Chromatogr B 736:247-253. doi: 10.1016/S0378-4347 (99) 00462-4
- (1999) J. Chromatogr. B. , vol.736 , pp. 247-253
- Swart, R.¹ Koivisto, P.² Markides, K.E.³

17
- 62249133672
- doi:10.1016/j.jchromb.2009.02.036
- Macek J, Ptacek P, Klima J (2009) J Chromatogr B 877:968-974. doi:10.1016/j.jchromb.2009.02.036
- (2009) J. Chromatogr. B. , vol.877 , pp. 968-974
- Macek, J.¹ Ptacek, P.² Klima, J.³

18
- 0005905707
- Guidance for Industry, US Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research CDER, Centre for Veterinary Medicine CVM, May
- Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veterinary Medicine (CVM), May 2001
- (2001) Bioanalytical Method Validation

19
- 0037663202
- Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS
- DOI 10.1021/ac020361s
- Matuszewski BK, Constanzer ML, Chavez-Eng CM (2003) Anal Chem 75:3019-3030. doi:10.1021/ac020361s (Pubitemid 36830428)
- (2003) Analytical Chemistry , vol.75 , Issue.13 , pp. 3019-3030
- Matuszewski, B.K.¹ Constanzer, M.L.² Chavez-Eng, C.M.³

20
- 77956505361
- Guidance for Industry: ICH E6 Good Clinical Practice, U. S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research CDER, Centre for Biologics Evaluation and Research CBER, April
- Guidance for Industry: ICH E6 Good Clinical Practice, U. S. Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Centre for Biologics Evaluation and Research (CBER), April 1996
- (1996)

21
- 38849144763
- Confirmatory reanalysis of incurred bioanalytical samples
- DOI 10.1208/aapsj0903040, 40
- Rocci ML Jr, Devanarayan V, Haughey DB, Jardieu P (2007) AAPS J 9: E336-E343. doi:10.1208/aapsj0903040 (Pubitemid 351816757)
- (2007) AAPS Journal , vol.9 , Issue.3
- Rocci Jr., M.L.¹ Devanarayan, V.² Haughey, D.B.³ Jardieu, P.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.